{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T05:59:27Z","timestamp":1789365567407,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10096-015-2404-z","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T05:45:57Z","timestamp":1431927957000},"page":"1675-1682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Influence of daily dosage and frequency of administration of rifampicin\u2013levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections"],"prefix":"10.1007","volume":"34","author":[{"given":"S.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Robineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Titecat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Blondiaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Loiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Beltrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Migaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Senneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,19]]},"reference":[{"key":"2404_CR1","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1128\/AAC.35.12.2611","volume":"35","author":"C Chuard","year":"1991","unstructured":"Chuard C, Herrmann M, Vaudaux P et al (1991) Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations. Antimicrob Agents Chemother 35:2611\u20132616","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR2","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1128\/AAC.34.12.2312","volume":"34","author":"JC Lucet","year":"1990","unstructured":"Lucet JC, Herrmann M, Rohner P et al (1990) Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 34:2312\u20132317","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","volume":"279","author":"W Zimmerli","year":"1998","unstructured":"Zimmerli W, Widmer AF, Blatter M et al (1998) Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 279:1537\u20131541","journal-title":"JAMA"},{"key":"2404_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10096-010-0952-9","volume":"29","author":"OC Helou El","year":"2010","unstructured":"El Helou OC, Berbari EF, Lahr BD et al (2010) Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis 29:961\u2013967","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2404_CR5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/cid\/cir402","volume":"53","author":"E Senneville","year":"2011","unstructured":"Senneville E, Joulie D, Legout L et al (2011) Outcome and predictors of treatment failure in total hip\/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 53:334\u2013340","journal-title":"Clin Infect Dis"},{"key":"2404_CR6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/cid\/cis746","volume":"56","author":"J Lora-Tamayo","year":"2013","unstructured":"Lora-Tamayo J, Murillo O, Iribarren JA et al (2013) A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 56:182\u2013194","journal-title":"Clin Infect Dis"},{"key":"2404_CR7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.idc.2004.04.003","volume":"18","author":"KS Kaye","year":"2004","unstructured":"Kaye KS, Engemann JJ, Fraimow HS et al (2004) Pathogens resistant to antimicrobial agents: epidemiology, molecular mechanisms, and clinical management. Infect Dis Clin North Am 18:467\u2013511","journal-title":"Infect Dis Clin North Am"},{"key":"2404_CR8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.8153626","volume":"264","author":"BG Spratt","year":"1994","unstructured":"Spratt BG (1994) Resistance to antibiotics mediated by target alterations. Science 264:388\u2013393","journal-title":"Science"},{"issue":"Suppl 3","key":"2404_CR9","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1093\/clinids\/5.Supplement_3.S440","volume":"5","author":"J Grosset","year":"1983","unstructured":"Grosset J, Leventis S (1983) Adverse effects of rifampicin. Rev Infect Dis 5(Suppl 3):S440\u2013S450","journal-title":"Rev Infect Dis"},{"key":"2404_CR10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archinte.162.9.985","volume":"162","author":"CK Finch","year":"2002","unstructured":"Finch CK, Chrisman CR, Baciewicz AM et al (2002) Rifampin and rifabutin drug interactions: an update. Arch Intern Med 162:985\u2013992","journal-title":"Arch Intern Med"},{"key":"2404_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2007.00490.x","volume":"21","author":"F Roblot","year":"2007","unstructured":"Roblot F, Besnier JM, Giraudeau B et al (2007) Lack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections. Fundam Clin Pharmacol 21:363\u2013369","journal-title":"Fundam Clin Pharmacol"},{"key":"2404_CR12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/521894","volume":"45","author":"HM Nijland","year":"2007","unstructured":"Nijland HM, Ruslami R, Suroto AJ et al (2007) Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis. Clin Infect Dis 45:1001\u20131007","journal-title":"Clin Infect Dis"},{"key":"2404_CR13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1128\/AAC.37.6.1214","volume":"37","author":"M Drancourt","year":"1993","unstructured":"Drancourt M, Stein A, Argenson JN et al (1993) Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 37:1214\u20131218","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/cis966","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR et al; Infectious Diseases Society of America (2013) Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:1\u201310","journal-title":"Clin Infect Dis"},{"key":"2404_CR15","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/jac\/dkh451","volume":"54","author":"F Frippiat","year":"2004","unstructured":"Frippiat F, Meunier F, Derue G (2004) Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 54:1158","journal-title":"J Antimicrob Chemother"},{"key":"2404_CR16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645\u20131654","journal-title":"N Engl J Med"},{"key":"2404_CR17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/9781555818067.ch9","volume-title":"Infections associated with indwelling medical devices","author":"JM Steckelberg","year":"2000","unstructured":"Steckelberg JM, Osmon DR (2000) Prosthetic joint infections. In: Waldvogel FA, Bisno AL (eds) Infections associated with indwelling medical devices, 3rd edn. ASM Press, Washington, pp 173\u2013209","edition":"3"},{"key":"2404_CR18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/978-1-4612-1406-9_53","volume-title":"Revision total hip arthroplasty","author":"GH Westrich","year":"1999","unstructured":"Westrich GH, Salvati EA, Brause B (1999) Postoperative infection. In: Bono JV, McCarthy JC, Thornhill TS, Bierbaum BE, Turner RH (eds) Revision total hip arthroplasty. Springer-Verlag, New York, pp 371\u2013390"},{"key":"2404_CR19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2106\/00004623-199807000-00004","volume":"80","author":"KJ Ure","year":"1998","unstructured":"Ure KJ, Amstutz HC, Nasser S et al (1998) Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up. J Bone Joint Surg Am 80:961\u2013968","journal-title":"J Bone Joint Surg Am"},{"key":"2404_CR20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2106\/00004623-199604000-00005","volume":"78","author":"DT Tsukayama","year":"1996","unstructured":"Tsukayama DT, Estrada R, Gustilo RB (1996) Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg Am 78:512\u2013523","journal-title":"J Bone Joint Surg Am"},{"key":"2404_CR21","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2106\/00004623-199072090-00018","volume":"72","author":"SD Schoifet","year":"1990","unstructured":"Schoifet SD, Morrey BF (1990) Treatment of infection after total knee arthroplasty by debridement with retention of the components. J Bone Joint Surg Am 72:1383\u20131390","journal-title":"J Bone Joint Surg Am"},{"key":"2404_CR22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/jac\/dkp107","volume":"63","author":"I Byren","year":"2009","unstructured":"Byren I, Bejon P, Atkins BL et al (2009) One hundred and twelve infected arthroplasties treated with \u2018DAIR\u2019 (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 63:1264\u20131271","journal-title":"J Antimicrob Chemother"},{"key":"2404_CR23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1099\/00222615-30-3-227","volume":"30","author":"CS Lewin","year":"1989","unstructured":"Lewin CS, Amyes SG (1989) The bactericidal activity of DR-3355, an optically active isomer of ofloxacin. J Med Microbiol 30:227\u2013231","journal-title":"J Med Microbiol"},{"key":"2404_CR24","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1128\/AAC.50.2.822-823.2006","volume":"50","author":"R Ruslami","year":"2006","unstructured":"Ruslami R, Nijland H, Aarnoutse R et al (2006) Evaluation of high- versus standard-dose rifampin in Indonesian patients with pulmonary tuberculosis. Antimicrob Agents Chemother 50:822\u2013823","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/39.2.235","volume":"39","author":"M Drancourt","year":"1997","unstructured":"Drancourt M, Stein A, Argenson JN et al (1997) Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin. J Antimicrob Chemother 39:235\u2013240","journal-title":"J Antimicrob Chemother"},{"key":"2404_CR26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.medmal.2009.05.003","volume":"39","author":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF)","year":"2009","unstructured":"Soci\u00e9t\u00e9 de Pathologie Infectieuse de Langue Fran\u00e7aise (SPILF); Coll\u00e8ge des Universitaires de Maladies Infectieuses et Tropicales (CMIT); Groupe de Pathologie Infectieuse P\u00e9diatrique (GPIP); Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation (SFAR); Soci\u00e9t\u00e9 Fran\u00e7aise de Chirurgie Orthop\u00e9dique et Traumatologique (SOFCOT); Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Hygi\u00e8ne Hospitali\u00e8re (SFHH); Soci\u00e9t\u00e9 Fran\u00e7aise de M\u00e9decine Nucl\u00e9aire (SFMN); Soci\u00e9t\u00e9 Fran\u00e7aise de M\u00e9decine Physique et de R\u00e9adaptation (SOFMER); Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie (SFM); Soci\u00e9t\u00e9 Fran\u00e7aise de Radiologie (SFR-Rad); Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie (SFR-Rhu) (2009) Recommendations for clinical practice. Osteo-articular infection therapy according to materials used (prosthesis, implants, osteosynthesis). Med Mal Infect 39:745\u2013774","journal-title":"Med Mal Infect"},{"key":"2404_CR27","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/AAC.02032-13","volume":"58","author":"F Valour","year":"2014","unstructured":"Valour F, Karsenty J, Bouaziz A et al (2014) Antimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 58:746\u2013755","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/ajhp\/59.21.2105","volume":"59","author":"BL Erstad","year":"2002","unstructured":"Erstad BL (2002) Which weight for weight-based dosage regimens in obese patients? Am J Health Syst Pharm 59:2105\u20132110","journal-title":"Am J Health Syst Pharm"},{"key":"2404_CR29","first-page":"901","volume-title":"Antimicrobial therapy and vaccines","author":"AB Morris","year":"1998","unstructured":"Morris AB, Kanyok TP, Scott J et al (1998) Rifamycins. In: Yu VL, Merigan TC, Barriere SL (eds) Antimicrobial therapy and vaccines. Lippincott Williams & Wilkins, Philadelphia, pp 901\u2013962"},{"key":"2404_CR30","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","volume":"51","author":"T Gumbo","year":"2007","unstructured":"Gumbo T, Louie A, Deziel MR et al (2007) Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin. Antimicrob Agents Chemother 51:3781\u20133788","journal-title":"Antimicrob Agents Chemother"},{"key":"2404_CR31","unstructured":"Kucers A, Crowe S, Grayson ML et al (1997) Rifampicin (rifampin). In: Kucers A, Crowe S, Grayson ML (eds) The use of antibiotics. A clinical review of antibacterial, antifungal and antiviral drugs, 5th edn. Butterworth-Heinemann, Oxford, pp 676\u2013708"},{"key":"2404_CR32","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1469-0691.2006.01463.x","volume":"12","author":"A Soriano","year":"2006","unstructured":"Soriano A, Garc\u00eda S, Bori G et al (2006) Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 12:930\u2013933","journal-title":"Clin Microbiol Infect"},{"key":"2404_CR33","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.41.12.2670","volume":"41","author":"CA Peloquin","year":"1997","unstructured":"Peloquin CA, Jaresko GS, Yong CL et al (1997) Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide. Antimicrob Agents Chemother 41:2670\u20132679","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 3","key":"2404_CR34","doi-asserted-by":"crossref","first-page":"S428","DOI":"10.1093\/clinids\/5.Supplement_3.S428","volume":"5","author":"G Acocella","year":"1983","unstructured":"Acocella G (1983) Pharmacokinetics and metabolism of rifampin in humans. Rev Infect Dis 5(Suppl 3):S428\u2013S432","journal-title":"Rev Infect Dis"},{"key":"2404_CR35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","volume":"54","author":"B Spellberg","year":"2012","unstructured":"Spellberg B, Lipsky BA (2012) Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis 54:393\u2013407","journal-title":"Clin Infect Dis"},{"key":"2404_CR36","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/AAC.00458-08","volume":"52","author":"O Murillo","year":"2008","unstructured":"Murillo O, Pach\u00f3n ME, Euba G et al (2008) Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection. Antimicrob Agents Chemother 52:3681\u20133686","journal-title":"Antimicrob Agents Chemother"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2404-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-015-2404-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-015-2404-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T02:58:26Z","timestamp":1566701906000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-015-2404-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,19]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["2404"],"URL":"https:\/\/doi.org\/10.1007\/s10096-015-2404-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,19]]}}}